The role of dupilumab in the management of idiopathic chronic eczematous eruption of aging

J Am Acad Dermatol. 2020 Nov;83(5):1533-1535. doi: 10.1016/j.jaad.2020.07.023. Epub 2020 Jul 15.

Authors

Neda Shahriari¹, Bruce Strober², Mona Shahriari²

Affiliations

¹ Department of Dermatology, University of Connecticut, Farmington, Connecticut. Electronic address: [email protected].
² Department of Dermatology, Yale University, New Haven, Connecticut; Central Connecticut Dermatology, Cromwell, Connecticut.

PMID: 32679275
DOI: 10.1016/j.jaad.2020.07.023

No abstract available

Publication types

Letter

MeSH terms

Age Factors
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized / therapeutic use*
Chronic Disease
Eczema / drug therapy*
Female
Humans
Male

Substances

Antibodies, Monoclonal, Humanized
dupilumab